Loading...
ULH is not a good buy right now. The stock is in a bearish trend (stacked bearish moving averages and negative MACD), fundamentals deteriorated sharply in 2025/Q3 (revenue down and a large net loss), and the only recent Street update is a Hold with a lowered price target. With earnings coming on 2026-02-11 (after hours) and no proprietary buy signals today, the near-term risk/reward is unfavorable for an impatient buyer. Best action: avoid/new money stays out (or sell/trim if held).
Trend/price levels: Price is ~16.2 post-market, below the pivot (16.832), which keeps the near-term bias bearish. Key support is S1 ~15.552 (then S2 ~14.762). Overhead resistance is R1 ~18.112 (then R2 ~18.902). Indicators: Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), confirming a downtrend. MACD histogram is negative (-0.196) but contracting, suggesting downside momentum is easing (not yet reversed). RSI(6) ~42 is neutral-to-weak (not oversold), so there’s no strong “snap-back” technical buy signal. Pattern-based forward view provided: ~60% chance of +0.42% next day, -1.47% next week, +17.73% next month—near term remains choppy/soft while a longer bounce is possible but not confirmed.
Intellectia Proprietary Trading Signals Intellectia Proprietary Trading Signals
with price below pivot; rallies likely face resistance near ~18.
Latest reported quarter: 2025/Q3. Revenue fell to $396.786M (-7.04% YoY). Net income dropped to -$74.772M (down -381.73% YoY). EPS was -2.84 (down -381.19% YoY). Gross margin declined to 26.37 (-21.70% YoY). Overall, growth and profitability trends deteriorated sharply in the latest quarter, which weakens the case for an immediate buy.
Recent change: On 2025-12-16, Stifel lowered ULH’s price target to $17 from $18 and maintained a Hold rating. Wall Street pro view (pros): The Hold suggests the stock isn’t seen as severely overvalued at these levels; the firm’s broader transport commentary highlights self-help/cost actions as potential drivers. Cons: The price-target cut and continued Hold indicate limited conviction in near-term upside and a more cautious stance for the group. From ~16.2, the $17 target implies only modest upside, not enough to justify taking immediate risk given weak recent financials. Influential/political trading: No recent congress trading data available; hedge fund and insider trend signals are neutral.